Achieving Equity in Genomic Testing for Breast Cancer Through Partner-Led Strategies and Policies

NCT05916378 | Completed

• 1 other identifier: 68742
• Study Type: observational
• Target: 514
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this study is to identify the barriers, and the extent of said barriers, to genomic testing for breast cancer patients among low-income and minority populations, particularly throughout Northern California. The investigators have created a survey that is available online for any patient with cancer to fill out voluntarily regarding their experiences to date. The survey is available at: https://stanforduniversity.qualtrics.com/jfe/form/SV\_7VElf8oesWcB3bE

Conditions

Breast Cancer

Keywords

Genomic Testing; Precision Breast Cancer Care; Precision Medicine

Outcome Measures

Primary Outcomes (1)

• Number of participants who fill out the survey and participate in the semi-structured interviews. [ Time Frame: 12 Months ]

  We will track the number of participants who fill out the survey for the 12 month duration of the study and the number of participants who participate in the semi-structured telephone interviews.

  12 Months

Study Arms (1)

Patients and Caregivers

We will survey 100 patients and 50 caregivers.

Eligibility Criteria

• Age: 18 Years - 99 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

We expect to recruit 150 participants for enrollment in phase 1. These participants will include 100 patients diagnosed with breast cancer and 50 caregivers. In phase 2, we expect to recruit 55 of our phase 1 survey participants to complete a one-time one-on-one in-depth interview.

You may qualify if:

• The patients must be 18 years or older.
• Patients who opt in to complete the survey.
• Patients must have the capacity to verbally consent for the interview.

You may not qualify if:

• Patients who under the age of 18 years old.

Sponsors & Collaborators

• Stanford University: lead
• The Latino Cancer Institute: collaborator

Study Sites (1)

Stanford University School of Medicine

Stanford, California, 94305, United States

Location

Related Publications (2)

• Mary Umahi Obasi et al. Achieving equity in genomic testing for breast cancer through partner-led strategies and policies.. J Clin Oncol 43, 11027-11027(2025). DOI:10.1200/JCO.2025.43.16_suppl.11027

  BACKGROUND

• Olomu MUO, Scherer C, Wood E, Escobar K, Moufarrej S, Kamran R, Muir S, Munoz F, Stern M, Gomez S, Blayney DW, Chew H, Tealer LM, Alanes A, Moorehead D, Sanchez M, Sanchez KB, Tinianov S, Duron Y, Patel MI. Assessing barriers to genomic testing in breast cancer among diverse patients: a qualitative community-engaged research study. Breast Cancer Res Treat. 2025 Dec 29;215(2):47. doi: 10.1007/s10549-025-07871-8.

  PMID: 41460588 RESULT

Related Links

• Related Info

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by Site; Neoplasms; Breast Diseases; Skin Diseases; Skin and Connective Tissue Diseases

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: June 14, 2023
• First Posted: June 23, 2023
• Study Start: May 22, 2023
• Primary Completion: July 15, 2025
• Study Completion: April 21, 2026
• Last Updated: April 30, 2026

Record last verified: 2026-04

Locations

US (1)